Duloxetine
Product Images NDC 50090-4011

9 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50090-4011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 01)

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 01)
Chemical structure of duloxetine hydrochloride, showing a naphthalene ring, thiophene ring, and an amine group with hydrochloride. This structural diagram represents the active ingredient duloxetine.*
FDA Label Image

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 02)

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 02)
A Kaplan-Meier survival curve showing the proportion of patients with relapse over time (days) from randomization in a study comparing Duloxetine and placebo treatments. The graph depicts time on the x-axis and proportion of patients with relapse on the y-axis, with separate curves for Duloxetine and placebo.*
FDA Label Image

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 03)

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 03)
A Kaplan-Meier curve graph showing the proportion of patients with relapse over time in days from randomization. The graph compares treatment with Duloxetine and placebo, with distinct lines representing each treatment group.*
FDA Label Image

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 04)

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 04)
A line graph depicting the percentage of patients improved on the y-axis against percent improvement in pain from baseline on the x-axis. The graph compares several groups: Duloxetine 60 mg BID, Duloxetine 60 mg QD, Duloxetine 20 mg QD, and Placebo, showing patient response to these treatments over varying levels of pain improvement.*
FDA Label Image

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 05)

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 05)
A line graph depicting the percentage of patients improved in relation to percent improvement in pain from baseline. It compares three groups: DLX 60mg twice daily (BID), DLX 60mg once daily (QD), and placebo. The x-axis represents percent improvement in pain, while the y-axis shows the percentage of patients improved, illustrating trends among the groups over the range of pain improvement percentages.*
FDA Label Image

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 06)

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 06)
A line graph comparing percentage of patients improved between placebo and Duloxetine 60/120 mg once daily. The x-axis shows percent improvement in pain from baseline, and the y-axis shows the percentage of patients improved. Two lines represent the treatment and placebo outcomes over different improvement thresholds.*
FDA Label Image

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 07)

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 07)
A line graph comparing the percentage of patients improved with Duloxetine 60 mg once daily versus placebo across different levels of percent improvement in pain from baseline (BOCF). The graph shows percent improvement on the x-axis and percentage of patients improved on the y-axis, with distinct lines for placebo and Duloxetine 60 mg daily.*
FDA Label Image

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 08)

Duloxetine Delayed-release Capsules (70fc874c 597f 4306 8e20 E93f2b8382a3 08)
A line chart comparing the percentage of patients improved over different levels of percent improvement in pain from baseline (BOCF) between placebo and Duloxetine 60/120 mg once daily treatment groups. The x-axis shows percent improvement in pain, while the y-axis shows the percentage of patients improved, with two trend lines illustrating the difference between placebo and Duloxetine.*
FDA Label Image

Label Image (Lbl500904011)

Label Image (Lbl500904011)
Duloxetine 20 mg capsule label from A-S Medication Solutions with NDC 50090-4011. The label includes storage instructions, dosage details as 44 delayed-release unit dose capsules, and packaging information. It also shows a lot number, a barcode, and a QR code for dosage package insert access.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.